Tetrathiomolybdate (TM)

DRUG2 trials

Sponsors

University of Michigan, University of Michigan Rogel Cancer Center

Conditions

Esophageal CarcinomaPsoriasis

Phase 2

A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris

CompletedNCT00113542

University of MichiganPsoriasis

Start: 2004-06-30End: 2005-06-30Target: 10Updated: 2015-05-21

Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma

CompletedNCT00176800

University of Michigan Rogel Cancer CenterEsophageal Carcinoma

Start: 2001-11-30End: 2013-05-31Updated: 2016-08-22